Jimmy Bhullar
Stock Analyst at JP Morgan
(3.83)
# 735
Out of 4,734 analysts
223
Total ratings
54.26%
Success rate
7.29%
Average return
Main Sectors:
Stocks Rated by Jimmy Bhullar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOYA Voya Financial | Maintains: Neutral | $87 → $82 | $69.67 | +17.70% | 16 | Jan 7, 2025 | |
| BHF Brighthouse Financial | Maintains: Underweight | $59 → $56 | $50.56 | +10.76% | 3 | Jan 7, 2025 | |
| RGA Reinsurance Group of America | Maintains: Neutral | $227 → $232 | $222.98 | +4.05% | 18 | Jan 7, 2025 | |
| MET MetLife | Maintains: Overweight | $86 → $88 | $86.78 | +1.41% | 5 | Jan 7, 2025 | |
| EQH Equitable Holdings | Maintains: Neutral | $45 → $53 | $51.68 | +2.55% | 5 | Jan 7, 2025 | |
| AFL Aflac | Maintains: Neutral | $90 → $94 | $106.49 | -11.73% | 15 | Jan 7, 2025 | |
| UNM Unum Group | Downgrades: Neutral | $74 → $79 | $74.98 | +5.36% | 7 | Jan 7, 2025 | |
| PFG Principal Financial Group | Upgrades: Overweight | $95 → $92 | $81.66 | +12.66% | 6 | Jan 7, 2025 | |
| RNR RenaissanceRe Holdings | Maintains: Neutral | $280 → $284 | $257.46 | +10.31% | 9 | Jan 3, 2025 | |
| MMC Marsh & McLennan | Maintains: Neutral | $230 → $235 | $215.23 | +9.19% | 10 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $251 → $256 | $243.68 | +5.06% | 7 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $294 → $296 | $269.48 | +9.84% | 10 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $46 | $41.23 | +11.57% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $106 | $95.51 | +10.98% | 12 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $394 | $366.17 | +7.60% | 13 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $83 | $75.09 | +10.53% | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $122 → $125 | $111.93 | +11.68% | 6 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $205 → $207 | $188.90 | +9.58% | 16 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $54 → $56 | $66.60 | -15.92% | 6 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $220 → $242 | $239.52 | +1.04% | 15 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $118 → $128 | $119.01 | +7.55% | 13 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $34 | $33.13 | +2.63% | 12 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $26 → $34 | $31.95 | +6.42% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $133 → $136 | $118.30 | +14.96% | 10 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $68 | $110.37 | -38.39% | 1 | Mar 31, 2023 |
Voya Financial
Jan 7, 2025
Maintains: Neutral
Price Target: $87 → $82
Current: $69.67
Upside: +17.70%
Brighthouse Financial
Jan 7, 2025
Maintains: Underweight
Price Target: $59 → $56
Current: $50.56
Upside: +10.76%
Reinsurance Group of America
Jan 7, 2025
Maintains: Neutral
Price Target: $227 → $232
Current: $222.98
Upside: +4.05%
MetLife
Jan 7, 2025
Maintains: Overweight
Price Target: $86 → $88
Current: $86.78
Upside: +1.41%
Equitable Holdings
Jan 7, 2025
Maintains: Neutral
Price Target: $45 → $53
Current: $51.68
Upside: +2.55%
Aflac
Jan 7, 2025
Maintains: Neutral
Price Target: $90 → $94
Current: $106.49
Upside: -11.73%
Unum Group
Jan 7, 2025
Downgrades: Neutral
Price Target: $74 → $79
Current: $74.98
Upside: +5.36%
Principal Financial Group
Jan 7, 2025
Upgrades: Overweight
Price Target: $95 → $92
Current: $81.66
Upside: +12.66%
RenaissanceRe Holdings
Jan 3, 2025
Maintains: Neutral
Price Target: $280 → $284
Current: $257.46
Upside: +10.31%
Marsh & McLennan
Jan 3, 2025
Maintains: Neutral
Price Target: $230 → $235
Current: $215.23
Upside: +9.19%
Jan 3, 2025
Maintains: Overweight
Price Target: $251 → $256
Current: $243.68
Upside: +5.06%
Jan 3, 2025
Maintains: Neutral
Price Target: $294 → $296
Current: $269.48
Upside: +9.84%
Jan 3, 2025
Maintains: Overweight
Price Target: $47 → $46
Current: $41.23
Upside: +11.57%
Jan 3, 2025
Maintains: Neutral
Price Target: $110 → $106
Current: $95.51
Upside: +10.98%
Jan 3, 2025
Maintains: Overweight
Price Target: $379 → $394
Current: $366.17
Upside: +7.60%
Jan 3, 2025
Maintains: Overweight
Price Target: $89 → $83
Current: $75.09
Upside: +10.53%
Oct 25, 2024
Maintains: Neutral
Price Target: $122 → $125
Current: $111.93
Upside: +11.68%
Oct 10, 2024
Maintains: Overweight
Price Target: $205 → $207
Current: $188.90
Upside: +9.58%
Aug 2, 2024
Maintains: Underweight
Price Target: $54 → $56
Current: $66.60
Upside: -15.92%
Jul 11, 2024
Maintains: Underweight
Price Target: $220 → $242
Current: $239.52
Upside: +1.04%
Jul 2, 2024
Maintains: Neutral
Price Target: $118 → $128
Current: $119.01
Upside: +7.55%
Jul 2, 2024
Maintains: Underweight
Price Target: $28 → $34
Current: $33.13
Upside: +2.63%
Jul 2, 2024
Maintains: Neutral
Price Target: $26 → $34
Current: $31.95
Upside: +6.42%
Feb 8, 2024
Maintains: Overweight
Price Target: $133 → $136
Current: $118.30
Upside: +14.96%
Mar 31, 2023
Maintains: Overweight
Price Target: $75 → $68
Current: $110.37
Upside: -38.39%